Prison Health w/ Dr. Erick Eiting

Please watch the latest episode of The Bulldozer Health Show!

In this episode Wendy is on location in New York, New York with Dr. Erick Eiting. The for-profit prison system is discussed in relation to health care and other social issues, as well as available healthcare for prisoners, healthy food, and much more! Sponsored in part by: The CT Medical Marijuana Critic, Total Hemp U.S., The Barling Clinic, Better Living Rx, and Sage Advice LLC.

 

Thanks for watching!

Peace,

Wendy Love Edge

http://www.bulldozerhealth.org

4/15 Fashion, Health and Wellness: A Family Event T and G newspaper article

Please join Bulldozer Health and Art Reach on 4/15 at Bull Mansion! Here s the latest article about the event:         http://www.telegram.com/news/20170407/bulldozer-health-event-set-for-april-15-at-bull-mansion

Pulse Magazine Article January 2017

http://thepulsemag.com/wordpress/2017/01/concert-series-focuses-on-alternative-care

We are so thrilled that The Pulse Magazine in Worcester MA covered our monthly concert series this month in this article! Please read!

If you are in or near Worcester MA, please join us for this monthly series. The next one is on January 13th at Spiritual Haze in Worcester MA. We have 3 bands:  Secret Sage, James Keyes, and Kara Bennett Music. There will be vendors, artists and amazing silent auction items. We are even auctioning off a FULL SCHOLARSHIP to Northeastern Institute of Cannabis worth $2,000!  This event is not only a fundraiser for Bulldozer Health Inc., but a full legalization of cannabis celebration!

Thanks again The Pulse Magazine!

Peace,

Wendy Love Edge

http://www.bulldozerhealth.org

Take back your health America!

Happy New Year!

2016 has been an amazing year for Bulldozer Health Inc. Here are just a few photos from the past year!  We held events, taped Bulldozer Health Shows, and helped people in MA, CT, RI, TX, and AR access alternative health care.  Through our relationship with Canna Care Docs we have helped more than 40 people to see a doctor and receive their certification for medicinal cannabis use for free or at a reduced cost.  We expanded our alternative health network in the 5 states mentioned as well.  We have also welcomed 35 bands to the Take back your health America stage. All in all, we fulfilled our mission of educating everyone about all of their health options, improving access to alternative health care and inspiring people to optimal health.  But there is still so much more work to do!

Join us in welcoming in the New Year, 2017!

We are very excited as we enter into the New Year that our nonprofit is continuing to grow.  As we welcome in our new Executive Director, Joe Delaney and continue to expand to new states, we know that 2017 will bring more growth and much needed help to many people.

Please consider making a tax deductible donation today at http://www.bulldozerhealth.org , so that we can continue to grow projects like our Take back your health America benefit concerts and Health Fairs,  Community Garden, The  Bulldozer Health Show Podcast and TV show, Compassion Cannabis project and much, much more.

Thank you to everyone who supports our cause.

Take back your health America!

Peace,

Wendy Love Edge

Founder, Bulldozer Health Inc.

The AMA Calls for Ban on Pharmaceutical Advertising

The AMA (American Medical Association) released the press release below on 11/17/15 regarding their recent decision to call for a ban on pharmaceutical advertising.  The Bulldozer Health Show has been in contact with the AMA, and they have no further statement at this time.

We are publishing  the press release though,  so that our readers and Bulldozer Health Show listeners have the most accurate information.

Please join the AMA and sign our petition to get the public health risk of pharmaceutical advertising off of television

 

http://petitions.moveon.org/sign/take-prescription-drug?source=c.em&r_by=11354194

Thank you!

Peace,

Wendy Love Edge

Take back your health America!

 

 

NEWS FROM THE AMA
FOR IMMEDIATE RELEASE
November 17, 2015

AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices

ATLANTA – Responding to the billions of advertising dollars being spent to promote prescription products, physicians at the Interim Meeting of the American Medical Association (AMA) today adopted new policy aimed at driving solutions to make prescription drugs more affordable.

Physicians cited concerns that a growing proliferation of ads is driving demand for expensive treatments despite the clinical effectiveness of less costly alternatives.

“Today’s vote in support of an advertising ban reflects concerns among physicians about the negative impact of commercially-driven promotions, and the role that marketing costs play in fueling escalating drug prices,” said AMA Board Chair-elect Patrice A. Harris, M.D., M.A. “Direct-to-consumer advertising also inflates demand for new and more expensive drugs, even when these drugs may not be appropriate.”

The United States and New Zealand are the only two countries in the world that allow direct-to-consumer advertising of prescription drugs. Advertising dollars spent by drug makers have increased by 30 percent in the last two years to $4.5 billion, according to the market research firm Kantar Media.

New AMA policy also calls for convening a physician task force and launching an advocacy campaign to promote prescription drug affordability by demanding choice and competition in the pharmaceutical industry, and greater transparency in prescription drug prices and costs.

“Physicians strive to provide the best possible care to their patients, but increases in drug prices can impact the ability of physicians to offer their patients the best drug treatments,” said Dr.  Harris. “Patient care can be compromised and delayed when prescription drugs are unaffordable and subject to coverage limitations by the patient’s health plan. In a worst-case scenario, patients forego necessary treatments when drugs are too expensive.”

New AMA policy responds to deepened concerns that anticompetitive behavior in a consolidated pharmaceutical marketplace has the potential to increase drug prices. The AMA will encourage actions by federal regulators to limit anticompetitive behavior by pharmaceutical companies attempting to reduce competition from generic manufacturers through manipulation of patent protections and abuse of regulatory exclusivity incentives.

The AMA will also monitor pharmaceutical company mergers and acquisitions, as well as the impact of such actions on drug prices. Patent reform is a key area for encouraging greater market-based competition and new AMA policy will support an appropriate balance between incentives for innovation on the one hand and efforts to reduce regulatory and statutory barriers to competition as part of the patent system.

Last month, the Kaiser Family Foundation released a report saying that a high cost of prescription drugs remains the public’s top health care priority. In the past few years, prices on generic and brand-name prescription drugs have steadily risen and experienced a 4.7 percent spike in 2015, according to the Altarum Institute Center for Sustainable Health Spending.

The AMA’s new policy recognizes that the promotion of transparency in prescription drug pricing and costs will help patients, physicians and other stakeholders understand how drug manufacturers set prices. If there is greater understanding of the factors that contribute to prescription drug pricing, including the research, development, manufacturing, marketing and advertising costs borne by pharmaceutical companies, then the marketplace can react appropriately.

# # #

Media Contact:
AMA Media Relations
(312) 464-4430
media@ama-assn.org

About the American Medical Association (AMA) The American Medical Association helps doctors help patients by uniting physicians nationwide to work on the most important professional, public health and health policy issues. The nation’s largest physician organization plays a leading role in shaping the future of medicine. For more information on the AMA, please visit http://www.ama-assn.org.